2nd ESMO consensus conference on lung cancer : early-stage non-small-cell lung cancer consensus on diagnosis, treatment and follow-up
Vansteenkiste, J., Crinò, L., Dooms, C., Douillard, J.Y., Faivre-Finn, C., Lim, E., Rocco, G., Senan, S., van Schil, P., Veronesi, G., Stahel, R., Peters, S., Felip, E., Kerr, K., Besse, B., Eberhardt, W., Edelman, M., Mok, T., O'Byrne, K., Novello, S., Bubendorf, L., Marchetti, A., Baas, P., Reck, M., Syrigos, K., Paz-Ares, L., Smit, E., Meldgaard, P., Adjei, A., Nicolson, M., Weder, W., de Ruysscher, D., Le Pechoux, C., de Leyn, P., & Westeel, V. (2014) 2nd ESMO consensus conference on lung cancer : early-stage non-small-cell lung cancer consensus on diagnosis, treatment and follow-up. Annals of Oncology, 25(8), pp. 1462-1474.
To complement the existing treatment guidelines for all tumour types, ESMO organises consensus conferences to focus on specific issues in each type of tumour. The 2nd ESMO Consensus Conference on Lung Cancer was held on 11-12 May 2013 in Lugano. A total of 35 experts met to address several questions on non-small-cell lung cancer (NSCLC) in each of four areas: pathology and molecular biomarkers, first-line/second and further lines in advanced disease, earlystage disease and locally advanced disease. For each question, recommendations were made including reference to the grade of recommendation and level of evidence. This consensus paper focuses on early-stage disease. © The Author 2014. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved.
Impact and interest:
Citation counts are sourced monthly from and citation databases.
These databases contain citations from different subsets of available publications and different time periods and thus the citation count from each is usually different. Some works are not in either database and no count is displayed. Scopus includes citations from articles published in 1996 onwards, and Web of Science® generally from 1980 onwards.
Citations counts from theindexing service can be viewed at the linked Google Scholar™ search.
|Item Type:||Journal Article|
|Keywords:||Consensus, Early disease, ESMO, Lung cancer, Non-small-cell lung cancer, cisplatin, fluorodeoxyglucose, navelbine, adjuvant therapy, article, bronchus stenosis, cancer adjuvant therapy, cancer radiotherapy, cancer risk, cancer screening, cancer staging, cancer surgery, cardiopulmonary exercise test, clinical assessment, comorbidity, computer assisted tomography, consensus development, coughing, European Society for Medical Oncology, fatigue, follow up, health care organization, hemoptysis, high risk population, human, incidence, low dose computed tomography, lung non small cell cancer, necrosis, positron emission tomography, priority journal, radiation pneumonia, randomized controlled trial (topic), rib fracture, risk assessment, skin irritation, stereotactic ablative radiotherapy, stereotactic treatment, tumor volume, video assisted thoracoscopic surgery|
|Subjects:||Australian and New Zealand Standard Research Classification > MEDICAL AND HEALTH SCIENCES (110000) > ONCOLOGY AND CARCINOGENESIS (111200)|
|Divisions:||Current > Schools > School of Biomedical Sciences
Current > QUT Faculties and Divisions > Faculty of Health
Current > Institutes > Institute of Health and Biomedical Innovation
|Deposited On:||04 Nov 2014 00:53|
|Last Modified:||27 Jan 2015 02:47|
Repository Staff Only: item control page